Skip to main content
. Author manuscript; available in PMC: 2018 Aug 3.
Published in final edited form as: Int J Clin Oncol. 2012 Oct 11;18(5):934–941. doi: 10.1007/s10147-012-0475-8

Table 3.

Summary of compartmental PK parameters for UNBS5162 by treatment group [Mean (SD)]

Group Dose (mg) K10 (h−1) Cmax (ng/mL) t1/2 α (h) t1/2 β (h) AUC (h ng/mL) CL (L/h) Vss (L)
1 30.2 0.632 (0.080) 419.6 (146.2) 0.51 (0.08) 7.48 (2.29) 958 (245) 32.4 (5.3) 206 (36)
2 64.6 0.499 (0.251) 612.6 (214.7) 0.64 (0.21) 8.19 (0.51) 1644 (279) 39.9 (6.2) 313 (33)
3 125.0 0.737 (0.240) 1428.9 (643.7) 0.42 (0.12) 6.94 (1.67) 3194 (1143) 43.1 (16.9) 280 (142)
4 169.9 0.564 (0.154) 1821.4 (893.6) 0.63 (0.16) 7.34 (0.91) 4252 (1709) 43.7 (14.1) 278 (99)
5 252.9 1.138 (0.370) 3847.7 (738.5) 0.33 (0.10) 6.56 (1.04) 6640 (2006) 39.7 (6.7) 202 (53)
6 311.0 0.963 (0.322) 3981.3 (1986.6) 0.28 (0.03) 7.57 (1.62) 10127 (4411) 35.1 (15.8) 245 (109)
7 433.7 1.352 (0.370) 6376.6 (321.3) 0.32 (0.06) 6.78 (1.34) 11631 (2161) 37.6 (4.9) 162 (45)
8 491.2 1.075 (0.231) 5913.7 (267.5) 0.33 (0.02) 7.94 (0.21) 12786 (1852) 39.2 (10.6) 233 (31)

K10 elimination rate, Cmax peak concentration, t1/2 α half-life associated with the rapid macro-rate constant alpha, t1/2 β half-life associated with the slow macro-rate constant beta, AUC area under the curve, CL total body clearance, Vss volume of distribution at steady state